-
Article - 04/02/2020
A “living pharmacy” crawls on the ocean floor off the coastline that stretches from Southern California to Mexico: biosyn Arzneimittel GmbH, a pharmaceutical company based in the city of Fellbach in southern Germany, produces a drug to treat bladder cancer, using the haemolymph, a vertebrate fluid equivalent to blood, of Megathura crenulata, commonly known as a giant keyhole limpet.
https://www.gesundheitsindustrie-bw.de/en/article/news/medicine-from-blue-blood-marine-snails
-
Producing valuable new products from waste materials - 07/01/2020
Eco-friendly and responsibly manufactured products are more in demand than ever before. Specific research is being carried out into materials and applications for a wide variety of uses. The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB is working with Hermetia Baruth GmbH on the vision of an insect biofactory that uses waste materials to produce a wide range of products such as biosurfactants, animal feed or foils.
https://www.biooekonomie-bw.de/en/articles/news/A-vision-insect-biorefineries-as-components-of-a-sustainable-bioeconomy
-
EIP-AGRI project coordination - 12/12/2019
Lentil plants, rarely cultivated in Central Europe in the twentieth century, are making a comeback. The "Rhizo-Linse"1 EIP-AGRI project aims to reintroduce old lentil varieties and make them appealing to farmers. A company called nadicom Gesellschaft für angewandte Mikrobiologie mbH is working on the development of an ecological product consisting of nodule bacteria that can improve lentil plant growth.
https://www.biooekonomie-bw.de/en/articles/news/nadicom-Rhizo-Linse-project-excellent-small-fertiliser-factories
-
Article - 30/09/2019
Autistic people have different gut microorganisms than non-autistic people. Researchers believe that a disturbed intestinal flora may play a role in developmental disorders of the brain such as autism. The emerging new field of metaproteomics could shed light onto the matter. A team led by Prof. Dr. Boris Macek from Tübingen has investigated the bacterial protein pool in the faeces of mice that display autistic behaviour.
https://www.gesundheitsindustrie-bw.de/en/article/news/do-gut-bacteria-have-something-to-do-with-autism
-
-
Article - 01/07/2019
Medicines should act as quickly as possible and ideally only at the site of disease. However, this may be difficult when the medicines are taken up via the digestive tract or the blood system. Researchers at the Max Planck Institute for Intelligent Systems in Stuttgart have now developed a biohybrid microrobot consisting of red blood cells and bacteria that can be loaded with active ingredients.
https://www.gesundheitsindustrie-bw.de/en/article/news/microswimmers-guided-drug-delivery
-
-
Article - 27/03/2019
Algae are frugal organisms. They require only light, water, minerals and carbon dioxide to be able to produce biomass. These properties will now be exploited economically in a two-year research project. Dr. Stefan Sebök from the University of Hamburg plans to study the holistic utilisation of degradation products of a biogas plant in Wallerstädten by linking them to land-based algae cultivation.
https://www.biooekonomie-bw.de/en/articles/news/residues-from-biogas-plants-as-feed-for-algae
-
Article - 05/03/2019
Almost all humans are infected with Epstein-Barr viruses (EBV), which are linked to the development of benign diseases such as infectious mononucleosis as well as several cancers. Scientists from the German Cancer Research Center have developed a new strategy for creating a vaccine that targets different EBV virus life phases and has the potential to provide effective protection against EBV infection.
https://www.gesundheitsindustrie-bw.de/en/article/news/vaccination-against-oncogenic-epstein-barr-viruses
-
Article - 29/01/2019
Completely new possibilities for research and gene therapy became available following the development of the CRISPR/Cas method for targeted modification of the genome. However, treatment with molecular scissors is not without risk as potential errors are stored in the genome forever. Scientists from Tübingen have developed an alternative method in which the intervention takes place at the RNA level using the body's own enzymes and is thus…
https://www.gesundheitsindustrie-bw.de/en/article/news/targeted-rna-editing-with-the-bodys-own-enzyme-activity
-
-
-
-
-
-
-
-
-
-
-
-
Dossier - 20/01/2014
What still sounds like science fiction to the general public has long been within reach for many years scientists have been able to manipulate neural activity selectively with light. They use different wavelengths to turn cells on and off as if they were a standard switch. Optogenetics is an emerging technology that combines optics and genetics. The technology is already used in many different ways for many different purposes by numerous research…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/optogenetics-switching-cell-activity-on-and-off-with-light
-
-
The 15-year history of RNA interference is not short on dramatic effects. It begins with the unexpected discovery and publication of the process of post-transcriptional gene silencing in 1998 for which the two Americans Andrew Fire and Craig Mello were awarded the Nobel Prize in Physiology or Medicine just eight years after their discovery. In 2001 Thomas Tuschl succeeded in switching off genes in human cells with small synthetic pieces of RNA…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/rna-interference-confidence-is-returning
-
-
-
Dossier - 15/04/2013
The increasing demand for functional foods clearly shows that the role of food is no longer just to meet an essential need. Food that offers additional nutritional benefits is becoming increasingly important for example food that is able to prevent or treat diseases. This kind of food is therefore interesting for consumers the food industry and the healthcare sector alike. Products based on plant raw materials are particularly in demand due to…
https://www.gesundheitsindustrie-bw.de/en/article/dossier/bioactive-plant-foods-more-than-just-filling
-
-
Dossier - 25/03/2013
Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences.
https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-goes-automated
-
Dossier - 25/03/2013
Processes that previously required pipetting analysis and production to be carried out manually are increasingly now controlled by automated systems. However this has not necessarily involved a complete reinvention of the wheel instead automation systems used in the plant construction and mechanical engineering sectors are being adapted and optimised for application in the life sciences.
https://www.biooekonomie-bw.de/en/articles/dossiers/biotechnology-goes-automated
-
Website address: https://www.biooekonomie-bw.de/en/search